Treatment with Kaftrio (elexacaftor/tezacaftor/ivacaftor) improved the pancreatic function of two women with cystic fibrosis (CF), allowing them to…
Articles by Andrea Lobo, PhD
Mental health issues — namely, attention-deficit/hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) — in children with cystic fibrosis…
Blood levels of an indicator of diabetes, glycated hemoglobin (HbA1c), fell within the first year that cystic fibrosis (CF)…
Treatment with CFTR modulators lessened the need for opioids and other painkillers in people with cystic fibrosis (CF),…
ViaNautis has secured $25 million in financing to advance work with polyNaut, its delivery platform for…
Six months of treatment with Trikafta (elexacaftor/tezacaftor/ivacaftor) significantly improved lung function and nutritional status in two adults with…
The pediatric and adult cystic fibrosis programs at Geisinger Medical Center have received an award from the Cystic Fibrosis…
Kaftrio and Symkevi — marketed in the U.S. as Trikafta and Symdeko, respectively — may be effective in…
Treatment with Kaftrio eased gastrointestinal symptoms in people with cystic fibrosis (CF), ages 12 and older, according to…
Electronic home monitoring using a spirometry device may help improve lung function in children with cystic fibrosis (CF), according…